Clinical Trial Update: Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing selective internal radiation therapy with capecitabine for resectable intrahepatic cholangiocarcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Selective Internal Radiation Therapy

Snippet

Sponsor: Center Eugene Marquis | Conditions: Resectable Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING